PuSH - Publication Server of Helmholtz Zentrum München

Wendtner, C.-M.* ; Abdel-Rahman, S.* ; Krych, M.* ; Baumert, J.J.* ; Lindner, L.H.* ; Baur, A.* ; Hiddemann, W.* ; Issels, R.D.

Response to Neoadjuvant Chemotherapy Combined with Regional Hyperthermia Predicts Long-Term Survival for Adult Patients with Retroperitoneal and Visceral High-Risk Soft Tissue Sarcomas.

J. Clin. Oncol. 20, 3156-3164 (2002)
Purpose: To determine the efficacy of neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for local tumor control and overall survival (OS) in adult patients with retroperitoneal or visceral (RP/V) high-risk soft tissue sarcomas (HR-STS).Patients and Methods: From 1991 to 1997, 58 patients with HR-STS at RP/V sites were prospectively treated with four cycles of etoposide, ifosfamide, and doxorubicin combined with RHT followed by surgery, adjuvant chemotherapy, and radiation.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords PROGNOSTIC FACTORS; PHASE-II; PREOPERATIVE CHEMOTHERAPY; RADIOTHERAPY; RECURRENT; EXTREMITY; HEAT; TRIAL; MANAGEMENT; RADIATION
ISSN (print) / ISBN 0732-183X
e-ISSN 1527-7755
Quellenangaben Volume: 20, Issue: , Pages: 3156-3164 Article Number: , Supplement: ,
Publisher American Society of Clinical Oncology
Non-patent literature Publications
Reviewing status Peer reviewed